Abstract 8 Health-Related Quality of Life (HRQL) Following Transplantation with Omidubicel Versus Umbilical Cord Blood (UCB) in Patients with Hematologic Malignancies: Results from a Phase III Randomized, Multicenter Study

Abstract Introduction Omidubicel, an advanced cell therapy used for allogeneic hematopoietic stem cell transplant has demonstrated faster hematopoietic recovery, shorter hospitalization, and lower rates of bacterial, viral, and invasive fungal infections compared with umbilical cord blood (UCB) in a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Stem cells translational medicine 2022-09, Vol.11 (Supplement_1), p.S10-S10
Hauptverfasser:	Lin, Chenyu, Sajeev, Gautam, Sung, Anthony, Stiff, Patrick, Brunstein, Claudio, Cutler, Corey, Sanz, Guillermo, Lindemans, Caroline, Rezvani, Andrew, Hanna, Rabi, Koh, Liang, Maziarz, Richard, Hwang, William, Song, Yan, Liu, Qing, Manghani, Rocio, Sivaraman, Smitha, Signorovitch, James, Horwitz, Mitchell
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Trials – Hematopoietic Stem Cell Therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!